找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Endocrine Therapy of Breast Cancer III; Franco Cavalli Conference proceedings 1989 Springer-Verlag Berlin Heidelberg 1989 breast cancer.ca

[復(fù)制鏈接]
樓主: KEN
11#
發(fā)表于 2025-3-23 10:32:37 | 只看該作者
https://doi.org/10.1007/978-1-4419-9096-9orly defined, we have generalised our method of comparing treatment attitudes to include individual qualitative judgment values. The generalisation includes: 1) a comparison of two populations based upon an overall value given to each period of life either with or without breast cancer related event
12#
發(fā)表于 2025-3-23 14:44:48 | 只看該作者
13#
發(fā)表于 2025-3-23 21:02:15 | 只看該作者
Control of Follicular Growth and Ovulationsm of oestradiol action to full oestrogen agonist effects in both animals and man [1,5]. This complex pharmacology raises a number of issues of importance to the therapeutic use of antioestrogens and, at a more fundamental level, to our understanding of the mode of action of oestrogens.
14#
發(fā)表于 2025-3-24 00:54:29 | 只看該作者
Progression from Steroid Responsive to Unresponsive State in Breast Cancer,nd different degrees of hormone sensitivity [3–5] have been helpful at the biological level but have not defined any of the underlying molecular events. Figure 1 depicts a generally accepted version of the current status of multi-pathway evolution of unresponsive tumours which will form the basis of
15#
發(fā)表于 2025-3-24 03:25:14 | 只看該作者
Integration of Quality-of-Life Issues into Clinical Trials of Breast Cancer,orly defined, we have generalised our method of comparing treatment attitudes to include individual qualitative judgment values. The generalisation includes: 1) a comparison of two populations based upon an overall value given to each period of life either with or without breast cancer related event
16#
發(fā)表于 2025-3-24 07:57:28 | 只看該作者
17#
發(fā)表于 2025-3-24 10:49:59 | 只看該作者
18#
發(fā)表于 2025-3-24 17:58:00 | 只看該作者
19#
發(fā)表于 2025-3-24 22:25:31 | 只看該作者
Drug Resistance,Normal cells and tissues are provided with selective means to protect them against endogenous substances produced in excess in the body or against toxic exogenous substances.
20#
發(fā)表于 2025-3-25 00:26:30 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-28 04:58
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
民权县| 申扎县| 达日县| 正镶白旗| 茶陵县| 额济纳旗| 运城市| 嵊泗县| 剑阁县| 新宾| 吉木萨尔县| 登封市| 应城市| 上杭县| 邛崃市| 马山县| 九寨沟县| 扎赉特旗| 正阳县| 比如县| 依安县| 安龙县| 樟树市| 伊通| 蒙城县| 英德市| 宣化县| 峨山| 长泰县| 通江县| 任丘市| 嵊州市| 辰溪县| 衡山县| 夏邑县| 商丘市| 大宁县| 乌海市| 商都县| 宕昌县| 垫江县|